FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

BLOOD PRODUCTS ADVISORY COMMITTEE

December 14, 2006

Slides

Overview of 21 CFR 50.24, Toby A. Silverman, M.D., OBRR, FDA (ppt) (htm)

Update of October 2006 Public Meeting on Emergency Research, Diane Maloney, J.D., FDA (ppt) (htm)

Overview of Hemoglobin-based Oxygen Carriers (HBOCs), Abdu I. Alayash, Ph.D., OBRR, FDA (ppt) (htm)

Introduction: Proposed Use of HBOC-201 in the RESUS (Restore Effective SUrvival in Shock, Laurence Landow, M.D., OBRR, FDA (ppt) (htm)

Sponsor Presentations, Dan Freilich, M.D., CDR, MC, USN, NMRC (ppt) (htm)

Sponsor Backup Slide, NMRC (ppt) (htm)

Studies of HBOC-201 in Animal Models of Hemorrhagic Shock, John R. Hess, M.D., Medical Director, Cancer Center Laboratory, Associate Director, Blood Bank, Department of Pathology, University of Maryland Medical School (ppt) (htm)

Studies of HBOC-201 in Animal Models of Hemorrhagic Shock, Thomas Hintze, Ph.D., Professor of Physiology, New York Medical College (ppt) (htm)

Studies of HBOC-201 in Animal Models of Hemorrhagic Shock, Carl Hauser, M.D., Visiting Professor of Surgery, Beth Israel Deaconess Medical Center (ppt) (htm)

FDA Presentation to BPAC: NMRC RESUS Protocol Using HBOC-201, Toby Silverman, M.D., OBRR, FDA (ppt) (htm)

Up | AC Home Page

Page last updated February 2, 2007 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management